213 related articles for article (PubMed ID: 15113903)
1. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
Berkhoff EG; Boon AC; Nieuwkoop NJ; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2004 May; 78(10):5216-22. PubMed ID: 15113903
[TBL] [Abstract][Full Text] [Related]
2. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
Bodewes R; Geelhoed-Mieras MM; Nieuwkoop NJ; Hanson JA; David CS; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Virus Res; 2011 Jan; 155(1):123-30. PubMed ID: 20863862
[TBL] [Abstract][Full Text] [Related]
3. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
[TBL] [Abstract][Full Text] [Related]
4. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
Berkhoff EG; Geelhoed-Mieras MM; Verschuren EJ; van Baalen CA; Gruters RA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Clin Exp Immunol; 2007 May; 148(2):296-306. PubMed ID: 17326762
[TBL] [Abstract][Full Text] [Related]
5. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2005 Sep; 79(17):11239-46. PubMed ID: 16103176
[TBL] [Abstract][Full Text] [Related]
6. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
7. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Boon AC; de Mutsert G; van Baarle D; Smith DJ; Lapedes AS; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Immunol; 2004 Feb; 172(4):2453-60. PubMed ID: 14764717
[TBL] [Abstract][Full Text] [Related]
8. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
9. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
Voeten JT; Bestebroer TM; Nieuwkoop NJ; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2000 Aug; 74(15):6800-7. PubMed ID: 10888619
[TBL] [Abstract][Full Text] [Related]
10. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
[TBL] [Abstract][Full Text] [Related]
11. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
[TBL] [Abstract][Full Text] [Related]
12. Emergence of new influenza A viruses which carry an escape mutation of the HLA-B27-restricted CTL epitope of NP in Japan.
Kashiwagi T; Hamada N; Iwahashi J; Hara K; Ueda T; Noguchi H; Toyoda T
Microbiol Immunol; 2000; 44(10):867-70. PubMed ID: 11128072
[TBL] [Abstract][Full Text] [Related]
13. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
[TBL] [Abstract][Full Text] [Related]
14. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
Price GE; Ou R; Jiang H; Huang L; Moskophidis D
J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
[TBL] [Abstract][Full Text] [Related]
15. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2002 Mar; 76(5):2567-72. PubMed ID: 11836437
[TBL] [Abstract][Full Text] [Related]
16. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
[TBL] [Abstract][Full Text] [Related]
17. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
Berkhoff EGM; Geelhoed-Mieras MM; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
J Gen Virol; 2007 Feb; 88(Pt 2):530-535. PubMed ID: 17251571
[TBL] [Abstract][Full Text] [Related]
19. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.
McMichael AJ; Gotch FM; Rothbard J
J Exp Med; 1986 Nov; 164(5):1397-406. PubMed ID: 2430041
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
Rimmelzwaan GF; Kreijtz JH; Bodewes R; Fouchier RA; Osterhaus AD
Vaccine; 2009 Oct; 27(45):6363-5. PubMed ID: 19840674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
